Our Partners

At Neuronostics we value collaboration and believe that it’s a prerequisite for making a tangible difference. We listen to the diverse views of people with lived experience, the healthcare sector, researchers and charities across the globe to understand what needs to change and how we can achieve it together.

Interested in becoming a partner?

NHS Organisations

BioEP has been used or studied across 29 NHS organisations, 27 trusts in England and 2 health boards in Wales, spanning adult and paediatric neurophysiology, first seizure clinics, and diagnostic and prognostic research.

England (27 trusts)

Trust

Alder Hey Children’s NHS Foundation Trust

Bedfordshire Hospitals NHS Foundation Trust

Birmingham and Solihull Mental Health NHS Foundation Trust

Cornwall Partnership NHS Foundation Trust

Great Ormond Street Hospital for Children NHS Foundation Trust

Great Western Hospitals NHS Foundation Trust

Imperial College Healthcare NHS Trust

Kingston and Richmond NHS Foundation Trust

Lancashire Teaching Hospitals NHS Foundation Trust

Maidstone and Tunbridge Wells NHS Trust

Manchester University NHS Foundation Trust

Northampton General Hospital NHS Trust

Northern Care Alliance NHS Foundation Trust

Nottingham University Hospitals NHS Trust

Royal Cornwall Hospitals NHS Trust

Royal Devon University Healthcare NHS Foundation Trust

Royal Free London NHS Foundation Trust

Royal United Hospitals Bath NHS Foundation Trust

The Royal Wolverhampton NHS Trust

St George’s University Hospitals NHS Foundation Trust

University College London Hospitals NHS Foundation Trust

University Hospital Southampton NHS Foundation Trust

University Hospitals Birmingham NHS Foundation Trust

University Hospitals Bristol and Weston NHS Foundation Trust

University Hospitals Dorset NHS Foundation Trust

University Hospitals of Leicester NHS Trust

Worcestershire Acute Hospitals NHS Trust

Wales (2 health boards)

Basis of Collaboration

OASIS paediatric study site

ECLIPSE prognostic study site (Luton and Dunstable)

NIHR portfolio validation study site

Sponsor of the NIHR portfolio validation study

OASIS paediatric study site

CITADEL and ECLIPSE study site

OASIS paediatric study site (St Mary’s)

CITADEL study site

ECLIPSE study site (Royal Preston Hospital)

OASIS paediatric study site

CITADEL study site

ECLIPSE study site (Salford); service evaluation

SBRI Healthcare Phase 2 paediatric BioEP contract

CITADEL study site

NIHR portfolio validation study and CITADEL site

CITADEL study site

ECLIPSE study site

CITADEL, ECLIPSE and PRISTINE study site; clinical service evaluation

NIHR portfolio validation study and CITADEL site

NIHR portfolio validation study, ECLIPSE and OASIS site

CITADEL and ECLIPSE study site (Queen Elizabeth)

NIHR portfolio validation study site

First in-service clinical evaluation, completed

CITADEL study site (Leicester General)

OASIS paediatric study site

Health board

Aneurin Bevan University Health Board

Swansea Bay University Health Board

Basis of Collaboration

NIHR portfolio validation study site (Royal Gwent Hospital)

ECLIPSE study site (Morriston); clinical service evaluation

Commercial Partners

Working alongside our commercial partners, we accelerate innovation and expand the reach of our digital biomarker technology, ensuring it delivers value to healthcare providers and patients alike.

Academic Partners

We collaborate with our academic partners on a range of research projects which underpin the development of our novel biomarkers and technology.

Charity Partners

We work closely with our charity partners on raising awareness of neurological conditions and with their user groups to trial our technology. They importantly help us communicate with the lived experience community.

Investors

We collaborate with our investor partners on strategic aims and progress towards key company milestones. Our investors include:

“We’re not just investors; our team is made up of practised entrepreneurs who have lived the startup journey. The result? An eye for promising ideas and the know-how to scale them. Expect more than funding; we offer a holistic partnership based on years of experience.”

“Our community of entrepreneurs and investors source world class scientific discoveries that impact society on a global scale. Our curiosity and focus allows us to back the exceptional scientists and founders creating this impact.”

“Our planet is facing a multitude of urgent challenges; from climate change, dwindling natural resources and rapid urbanisation, to a growing demand for accessible healthcare. These pressing issues call for innovative and sustainable solutions that only scientific advancements can provide. We back century-defining technologies that advance human capability.”

Become a partner

Interested in working together?

We are interested in partnering with academic researchers, healthcare professionals, industry, and people with lived experience of Epilepsy, to validate and translate novel biomarkers for neurological conditions, co-develop technologies to solve real-world problems, and trial products in real world settings.